Stem Cell Authority (SCAL) Price & Analysis

9 Followers

SCAL Stock Chart & Stats

$0.02

$0.00(0.00%)

At close: Jul 06 4:00 PM EDT

$0.02

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.02 - $0.02

Previous CloseN/A

Volume3.31K

Average Volume (3M)2.32K

Market Cap

$2.44M

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-22.22

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding12,180,000,000

10 Day Avg. Volume2,301

30 Day Avg. Volume2,318

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SCAL FAQ

What was Stem Cell Authority Ltd.’s price range in the past 12 months?

Stem Cell Authority Ltd. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Stem Cell Authority Ltd.’s market cap?

Stem Cell Authority Ltd.’s market cap is $2.44M.

When is Stem Cell Authority Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Stem Cell Authority Ltd.’s earnings last quarter?

Currently, no data Available

Is Stem Cell Authority Ltd. overvalued?

According to Wall Street analysts Stem Cell Authority Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Stem Cell Authority Ltd. pay dividends?

Stem Cell Authority Ltd. does not currently pay dividends.

What is Stem Cell Authority Ltd.’s EPS estimate?

Stem Cell Authority Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Stem Cell Authority Ltd. have?

Stem Cell Authority Ltd. has 12,180,000,000 shares outstanding.

What happened to Stem Cell Authority Ltd.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Stem Cell Authority Ltd.?

Currently, no hedge funds are holding shares in SCAL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Stem Cell Authority Ltd.

Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced from umbilical cord blood, and "Miracle Mesenchymal" stem cells, derived from the Wharton's jelly found within a newborn's umbilical cord. SCAL provides healthcare professionals involved in childbirth throughout the United States with advanced technology to offer these vital stem cell preservation services to their maternity patients. The company's operations are based in Fairlawn, Ohio.